The future of medical congresses

Remember when pharma invested an enormous amount of time, effort and money into attending medical congresses around the world?    In the pandemic-blighted present, where all such global physical events have been put on hold, it seems an age away.    Many organisations – Reuters Events Pharma and ASCO to name but two - took immediate action and successfully transitioned their events to a digital format in record time; others were more risk-averse and chose to postpone events pending more certainty.  So what ' s going to happen to medical congresses now? Christoph Schmidt, former Global Head of Commercial Excellence at Actelion Pharmaceuticals believes the pandemic accelerated a trend that was already moving towards a more digitally mature set-up.    He predicts that the days of mega congresses, where upwards of 100,000 physicians would travel from all over the world to congregate in a single venue, are over. “In the future such events will be on a much smaller scale with broadcasts over social media and information sharing through different channels,” says Schmidt.  He points to research that shows the information-seeking preferences of healthcare professionals have changed over the years. Many now demanding content in a format, on a channel and at a time that is convenient to them. Jessica Federer, Former Chief Digital Officer at Bayer, agrees: “The trend was already moving away from having so many people come together physically because the travel, ec...
Source: EyeForPharma - Category: Pharmaceuticals Authors: Source Type: news